+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

North America Neurovascular Devices Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product; Application; End User and Country

  • PDF Icon

    Report

  • 109 Pages
  • November 2020
  • Region: North America
  • The Insight Partners
  • ID: 5231376
UP TO OFF until Jun 30th 2024
According to a new market research study of “North America Neurovascular Devices Market Forecast to 2027 - COVID-19 Impact and Analysis by Product, Application, and End User, The North America neurovascular devices market is expected to reach US$ 1389.28 Mn in 2027 from US$ 1,004.75 Mn in 2019. The market is estimated to grow with a CAGR of 4.2% from 2020-2027. The report highlights trends prevailing in the North America Neurovascular Devices Market instruments market and the factors driving market along with those that act as hindrances.

The North America neurovascular devices market, based on the product was segmented into neurothrombectomy devices, aneurysm coiling & embolization devices, cerebral balloon angioplasty & stenting systems and support devices. The aneurysm coiling & embolization devices held the largest share of the market in 2019, and is expected to register the highest CAGR in the market during the forecast period.

Neurovascular devices are used for the treatment of neurovascular diseases that possibly affects the network of blood vessels that surround the brain. This leads to incurable conditions such as strokes and aneurysms. Neurovascular devices are used to prevent stroke, aneurysm embolization, carotid stenosis and other symptoms. Neurovascular devices are also used for performing surgical procedures to treat aneurysms and other cranial blood flow problems. The prevalence of cerebral aneurysms has increased tremendously across the globe. Nearly, 30,000 people in the United States suffer from brain aneurysm rupture every year. A brain aneurysm ruptures every 18 minutes. The annual rate of rupture in the United States is found close to 8 to 10 per 100,000 people. Thus, it is estimated that the rising prevalence of cerebral aneurysms is likely to fuel the growth of the market during the forecast period.

Key factors that are driving growth of the North America Neurovascular Devices market are Increasing Incidences of neurovascular diseases, rising demand for minimally invasive procedures, and significantly growing aging population. However, the market is expected to grow at slower pace owing to the factors such as high cost of embolization coils and lack of expert professionals operating neurovascular disorders.

Penumbra, Inc.; Stryker Corporation; and Medtronic plc are among the leading companies operating in the North America Neurovascular Devices market.

Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America North America Neurovascular Devices Market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the North America North America Neurovascular Devices Market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Neurovascular Devices Market - by Product
1.3.2 North America Neurovascular Devices Market - by Application
1.3.3 North America Neurovascular Devices Market - by End User
1.3.4 North America Neurovascular Devices Market - by Geography
2. North America Neurovascular Devices Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Neurovascular Devices- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
5. North America Neurovascular Devices Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Incidences of Neurovascular Diseases
5.1.2 Rising Demand for Minimally Invasive Procedures
5.1.3 Significantly Growing Geriatric Population
5.2 Key Market Restraints
5.2.1 High Cost of Embolization Coils
5.2.2 Lack of Expert Professionals
5.3 Key Market Opportunities
5.3.1 Development in the Healthcare Market
5.4 Future Trends
5.4.1 Enduring Clinical Trials for the Treatment of Stroke
5.5 Impact Analysis of Drivers and Restraints
6. Neurovascular Devices Market - North America Analysis
6.1 North America Neurovascular Devices Market Revenue Forecasts and Analysis
7. Neurovascular Devices Market Analysis and Forecasts to 2027 Product
7.1 Overview
7.2 North America Neurovascular Devices Market Share by Product 2019 & 2027 (%)
7.3 Neurothrombectomy Devices
7.3.1 Overview
7.3.2 Neurothrombectomy Devices Market Revenue and Forecast to 2027 (US$ Mn)
7.3.3 Clot Retrieval Devices
7.3.3.1 Clot Retrieval Devices Market Revenue and Forecast to 2027 (US$ Mn)
7.3.4 Snares
7.3.4.1 Snares Market Revenue and Forecast to 2027 (US$ Mn)
7.3.5 Suction & Aspiration Devices
7.3.5.1 Suction & Aspiration Devices Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Aneurysm Coiling & Embolization Devices
7.4.1 Overview
7.4.2 Aneurysm Coiling & Embolization Devices Market Revenue and Forecast to 2027 (US$ Mn)
7.4.3 Embolic Coils
7.4.3.1 Embolic Coils Market Revenue and Forecast to 2027 (US$ Mn)
7.4.3.2 Bare Detachable Coils
7.4.3.2.1 Bare Detachable Coils Market Revenue and Forecast to 2027 (US$ Mn)
7.4.3.3 Coated Detachable Coils
7.4.3.3.1 Coated Detachable Coils Market Revenue and Forecast to 2027 (US$ Mn)
7.4.4 Flow Diversion Devices
7.4.4.1 Flow Diversion Devices Market Revenue and Forecast to 2027 (US$ Mn)
7.4.5 Liquid Embolic Agents
7.4.5.1 Liquid Embolic Agents Market Revenue and Forecast to 2027 (US$ Mn)
7.5 Cerebral Balloon Angioplasty & Stenting Systems
7.5.1 Overview
7.5.2 Cerebral Balloon Angioplasty & Stenting Systems Market Revenue and Forecast to 2027 (US$ Mn)
7.5.3 Carotid Artery Stents
7.5.3.1 Carotid Artery Stents Market Revenue and Forecast to 2027 (US$ Mn)
7.5.4 Embolic Protection Systems
7.5.4.1 Embolic Protection Systems Market Revenue and Forecast to 2027 (US$ Mn)
7.5.4.2 Balloon Occlusion Devices
7.5.4.2.1 Balloon Occlusion Devices Market Revenue and Forecast to 2027 (US$ Mn)
7.5.4.3 Distal Fillers
7.5.4.3.1 Distal Fillers Market Revenue and Forecast to 2027 (US$ Mn)
7.6 Support Devices
7.6.1 Overview
7.6.2 Support Devices Market Revenue and Forecast to 2027 (US$ Mn)
7.6.3 Microcatheters
7.6.3.1 Microcatheters Market Revenue and Forecast to 2027 (US$ Mn)
7.6.4 Microguidewires
7.6.4.1 Microguidewires Market Revenue and Forecast to 2027 (US$ Mn)
8. Neurovascular Devices Market Analysis and Forecasts to 2027- Application
8.1 Overview
8.2 North America Neurovascular Devices Market Share by Application 2019 & 2027 (%)
8.3 Cerebral Aneurysms
8.3.1 Overview
8.3.2 Cerebral Aneurysms Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Ischemic Strokes
8.4.1 Overview
8.4.2 Ischemic Strokes Market Revenue and Forecast to 2027 (US$ Mn)
8.5 Arteriovenous Malformation & Fistulas
8.5.1 Overview
8.5.2 Arteriovenous Malformation & Fistulas Market Revenue and Forecast to 2027 (US$ Mn)
8.6 Other Applications
8.6.1 Overview
8.6.2 Other Applications Market Revenue and Forecast to 2027 (US$ Mn)
9. Neurovascular Devices Market Analysis and Forecasts to 2027 - End User
9.1 Overview
9.2 North America Neurovascular Devices Market Share, by End User, 2019 and 2027 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals Market Revenue and Forecast to 2027 (US$ Mn)
9.4 Ambulatory Surgical Centers
9.4.1 Overview
9.4.2 Ambulatory Surgical Centers Market Revenue and Forecast to 2027 (US$ Mn)
9.5 Specialized Clinics
9.5.1 Overview
9.5.2 Specialized Clinics Market Revenue and Forecast to 2027 (US$ Mn)
10. Neurovascular Devices Market - Geographic Analysis
10.1 North America Neurovascular Devices Market
10.1.1 Overview
10.2 North America Neurovascular Devices Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.1 North America Neurovascular Devices Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.2 North America Neurovascular Devices Market Revenue and Forecasts to 2027, by Product (US$ Mn)
10.2.2.1 North America Neurothrombectomy Devices Market Revenue and Forecasts to 2027, by Type (US$ Mn)
10.2.2.2 North America Aneurysm Coiling & Embolization Devices Market Revenue and Forecasts to 2027, by Type (US$ Mn)
10.2.2.3 North America Embolic Coils Market Revenue and Forecasts to 2027, by Type (US$ Mn)
10.2.2.4 North America Cerebral Balloon Angioplasty & Stenting Systems Market Revenue and Forecasts to 2027, by Type (US$ Mn)
10.2.2.5 North America Embolic Protection Systems Market Revenue and Forecasts to 2027, by Type (US$ Mn)
10.2.2.6 North America Support Devices Market Revenue and Forecasts to 2027, by Type (US$ Mn)
10.2.3 North America Neurovascular Devices Market Revenue and Forecasts to 2027, by Application (US$ Mn)
10.2.4 North America Neurovascular Devices Market Revenue and Forecasts to 2027, by End User (US$ Mn)
10.2.5 North America Neurovascular Devices Market Revenue and Forecasts to 2027, by Country (%)
10.2.6 US Neurovascular Devices Market
10.2.6.3 US Neurothrombectomy Devices Market Revenue and Forecasts to 2027, by Type (US$ Mn)
10.2.6.4 US Aneurysm Coiling & Embolization Devices Market Revenue and Forecasts to 2027, by Type (US$ Mn)
10.2.6.5 US Embolic Coils Market Revenue and Forecasts to 2027, by Type (US$ Mn)
10.2.6.6 US Cerebral Balloon Angioplasty & Stenting Systems Market Revenue and Forecasts to 2027, by Type (US$ Mn)
10.2.6.7 US Embolic Protection Systems Market Revenue and Forecasts to 2027, by Type (US$ Mn)
10.2.6.8 US Support Devices Market Revenue and Forecasts to 2027, by Type (US$ Mn)
10.2.7 Canada Neurovascular Devices Market
10.2.7.3 Canada Neurothrombectomy Devices Market Revenue and Forecasts to 2027, by Type (US$ Mn)
10.2.7.4 Canada Aneurysm Coiling & Embolization Devices Market Revenue and Forecasts to 2027, by Type (US$ Mn)
10.2.7.5 Canada Embolic Coils Market Revenue and Forecasts to 2027, by Type (US$ Mn)
10.2.7.6 Canada Cerebral Balloon Angioplasty & Stenting Systems Market Revenue and Forecasts to 2027, by Type (US$ Mn)
10.2.7.7 Canada Embolic Protection Systems Market Revenue and Forecasts to 2027, by Type (US$ Mn)
10.2.7.8 Canada Support Devices Market Revenue and Forecasts to 2027, by Type (US$ Mn)
10.2.8 Mexico Neurovascular Devices Market
10.2.8.3 Mexico Neurothrombectomy Devices Market Revenue and Forecasts to 2027, by Type (US$ Mn)
10.2.8.4 Mexico Aneurysm Coiling & Embolization Devices Market Revenue and Forecasts to 2027, by Type (US$ Mn)
10.2.8.5 Mexico Embolic Coils Market Revenue and Forecasts to 2027, by Type (US$ Mn)
10.2.8.6 Mexico Cerebral Balloon Angioplasty & Stenting Systems Market Revenue and Forecasts to 2027, by Type (US$ Mn)
10.2.8.7 Mexico Embolic Protection Systems Market Revenue and Forecasts to 2027, by Type (US$ Mn)
10.2.8.8 Mexico Support Devices Market Revenue and Forecasts to 2027, by Type (US$ Mn)
11. Impact Of COVID-19 Pandemic on North America Neurovascular Devices Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Neurovascular Devices Market-Key Company Profiles
12.1 Medtronic plc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Financial Overview
12.1.4 Product Portfolio
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Stryker Corporation
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Financial Overview
12.2.4 Product Portfolio
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Johnson & Johnson Services, Inc. (DePuy Synthes)
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Financial Overview
12.3.4 Product Portfolio
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Penumbra, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Financial Overview
12.4.4 Product Portfolio
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Terumo Corporation
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Financial Overview
12.5.4 Product Portfolio
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 MicroPort Scientific Corporation
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Financial Overview
12.6.4 Product Portfolio
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Integer Holdings Corporation
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Financial Overview
12.7.4 Product Portfolio
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Memry Corporation
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Financial Overview
12.8.4 Product Portfolio
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 phenox GmbH
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Financial Overview
12.9.4 Product Portfolio
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About the Publisher
13.2 Glossary of Terms
List of Tables
Table 1. North America Neurovascular Devices Market Revenue and Forecasts to 2027, by Product (US$ Mn)
Table 2. North America Neurothrombectomy Devices Market Revenue And Forecasts to 2027, by Type (US$ Mn)
Table 3. North America Aneurysm Coiling & Embolization Devices Market Revenue and Forecasts to 2027, by Type (US$ Mn)
Table 4. North America Embolic Coils Market Revenue and Forecasts to 2027, by Type (US$ Mn)
Table 5. North America Cerebral Balloon Angioplasty & Stenting Systems Market Revenue And Forecasts to 2027, by Type (US$ Mn)
Table 6. North America Embolic Protection Systems Market Revenue And Forecasts to 2027, by Type (US$ Mn)
Table 7. North America Support Devices Market Revenue and Forecasts to 2027, by Type (US$ Mn)
Table 8. North America Neurovascular Devices Market Revenue and Forecasts to 2027, by Application (US$ Mn)
Table 9. North America Neurovascular Devices Market Revenue And Forecasts to 2027, by End User (US$ Mn)
Table 10. US Neurovascular Devices Market Revenue and Forecasts to 2027, by Product (US$ Mn)
Table 11. US Neurothrombectomy Devices Market Revenue And Forecasts to 2027, by Type (US$ Mn)
Table 12. US Aneurysm Coiling & Embolization Devices Market Revenue and Forecasts to 2027, by Type (US$ Mn)
Table 13. US Embolic Coils Market Revenue and Forecasts to 2027, by Type (US$ Mn)
Table 14. US Cerebral Balloon Angioplasty & Stenting Systems Market Revenue and Forecasts to 2027, by Type (US$ Mn)
Table 15. US Embolic Protection Systems Market Revenue and Forecasts to 2027, by Type (US$ Mn)
Table 16. US Support Devices Market Revenue and Forecasts to 2027, by Type (US$ Mn)
Table 17. US Neurovascular Devices Market Revenue and Forecasts to 2027, by Application (US$ Mn)
Table 18. US Neurovascular Devices Market Revenue and Forecasts to 2027, by End User (US$ Mn)
Table 19. Canada Neurovascular Devices Market Revenue and Forecasts to 2027, by Product (US$ Mn)
Table 20. Canada Neurothrombectomy Devices Market Revenue and Forecasts to 2027, by Type (US$ Mn)
Table 21. Canada Aneurysm Coiling & Embolization Devices Market Revenue And Forecasts to 2027, by Type (US$ Mn)
Table 22. Canada Embolic Coils Market Revenue And Forecasts to 2027, by Type (US$ Mn)
Table 23. Canada Cerebral Balloon Angioplasty & Stenting Systems Market Revenue And Forecasts to 2027, by Type (US$ Mn)
Table 24. Canada Embolic Protection Systems Market Revenue and Forecasts to 2027, by Type (US$ Mn)
Table 25. Canada Support Devices Market Revenue And Forecasts to 2027, by Type (US$ Mn)
Table 26. Canada Neurovascular Devices Market Revenue and Forecasts to 2027, by Application (US$ Mn)
Table 27. Canada Neurovascular Devices Market Revenue And Forecasts to 2027, by End User (US$ Mn)
Table 28. Mexico Neurovascular Devices Market Revenue and Forecasts to 2027, by Product (US$ Mn)
Table 29. Mexico Neurothrombectomy Devices Market Revenue And Forecasts to 2027, by Type (US$ Mn)
Table 30. Mexico Aneurysm Coiling & Embolization Devices Market Revenue And Forecasts to 2027, by Type (US$ Mn)
Table 31. Mexico Embolic Coils Market Revenue and Forecasts to 2027, by Type (US$ Mn)
Table 32. Mexico Cerebral Balloon Angioplasty & Stenting Systems Market Revenue And Forecasts to 2027, by Type (US$ Mn)
Table 33. Mexico Embolic Protection Systems Market Revenue And Forecasts to 2027, by Type (US$ Mn)
Table 34. Mexico Support Devices Market Revenue and Forecasts to 2027, by Type (US$ Mn)
Table 35. Mexico Neurovascular Devices Market Revenue and Forecasts to 2027, by Application (US$ Mn)
Table 36. Mexico Neurovascular Devices Market Revenue and Forecasts to 2027, by End User (US$ Mn)
Table 37. Glossary of Terms, Neurovascular Devices Market
List of Figures
Figure 1. Neurovascular Devices Market Segmentation
Figure 2. Neurovascular Devices Segmentation, by Region
Figure 3. North America Neurovascular Devices Market Overview
Figure 4. Support Devices Segment Held Largest Share of the Product Segment in Neurovascular Devices Market
Figure 5. North America Neurovascular Devices Market - Leading Country Markets (US$ Mn)
Figure 6. North America PEST Analysis
Figure 7. Neurovascular Devices Market Impact Analysis of Drivers and Restraints
Figure 8. North America Neurovascular Devices Market - by Geography Forecasts and Analysis-2019-2027
Figure 9. North America Neurovascular Devices Market Share by Product 2019 & 2027 (%)
Figure 10. Neurothrombectomy Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. Clot Retrieval Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. Snares Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. Suction & Aspiration Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. Aneurysm Coiling & Embolization Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. Embolic Coils Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. Bare Detachable Coils Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. Coated Detachable Coils Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. Flow Diversion Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. Liquid Embolic Agents Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. Cerebral Balloon Angioplasty & Stenting Systems Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Carotid Artery Stents Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. Embolic Protection Systems Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. Balloon Occlusion Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. Distal Fillers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. Support Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. Microcatheters Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 27. Microguidewires Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 28. North America Neurovascular Devices Market Share by Application 2019 & 2027 (%)
Figure 29. Cerebral Aneurysms Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 30. Ischemic Strokes Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 31. Arteriovenous Malformation & Fistulas Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 32. Other Applications Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 33. North America Neurovascular Devices Market Share, by End User, 2019 & 2027 (%)
Figure 34. Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 35. Ambulatory Surgical Centers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 36. Specialized Clinics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 37. North America Neurovascular Devices Market Revenue Overview, by Country (2019) (US$ Mn)
Figure 38. North America Neurovascular Devices Market Revenue and Forecasts to 2027, by Country (%)
Figure 39. US Neurovascular Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 40. Canada Neurovascular Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 41. Mexico Neurovascular Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 42. Impact of COVID-19 Pandemic in North American Country Markets

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Medtronic plc
  • Johnson and Johnson, Inc (DePuy Synthes)
  • Penumbra, Inc
  • Terumo Corporation
  • MicroPort Scientific Corporation
  • Integer Holdings Corporation
  • Memry Corporation
  • Phenox GmbH